Syneos Health opens Global Life Sciences and Technology Centre in Hyderabad
The 137,000-sq-ft centre, Syneos Health’s largest in Asia, will bring together clinical, commercial, scientific, technology and AI capabilities with an initial workforce of more than 700 professionals.
From left to right - Sarvesh Singh, CEO, Telangana Lifesciences; Sai Krishna, IT Advisor, Govt of Telangana; Mike Montello, Chief Digital, and Information Officer, Syneos Health; Tom Wollman, Global Head of Operational Excellence, Syneos Health; D. Sridhar Babu, ITEC & Industries Minister; and Jinu Jose, SVP & GM Global GCC, Syneos Health
HYDERABAD: Syneos Health has opened its new Global Life Sciences and Technology Centre in Hyderabad, adding to the city’s growing concentration of life sciences, healthcare and technology capabilities. The 137,000-sq-ft facility is the company’s largest centre in Asia and its third-largest globally, with an initial workforce of more than 700 professionals.
The centre was inaugurated by Telangana IT and Industries Minister D. Sridhar Babu in the presence of senior Syneos Health executives and Telangana government officials. The new facility brings together capabilities spanning clinical development, commercialisation, medical affairs, technology, artificial intelligence and corporate functions.
Hyderabad emerges as life sciences and technology hub
Syneos Health said the Hyderabad centre is being positioned as a strategic growth hub rather than a conventional delivery centre, with global leaders and teams based in the city supporting drug development and commercialisation for customers worldwide.
According to the company, Hyderabad accounts for 20–23% of India’s healthcare-biotech GCC market, supported by Telangana’s end-to-end life sciences ecosystem covering APIs, bulk drugs, generics, CDMO, vaccines, research and discovery.
With Syneos Health joining the ecosystem, the company said four of the world’s top five Contract Research Organisations (CROs) now have a presence in Hyderabad.
Syneos Health’s existing Hyderabad AI operations are also focused on clinical development, safety and commercialisation, including AI-driven protocol design, predictive analytics, intelligent assistants, pharmacovigilance applications and generative AI systems for life sciences.
Focus on AI-enabled life sciences
Sridhar Babu said Hyderabad’s established life sciences ecosystem and technology talent pool provide an opportunity to combine science and AI to develop new healthcare capabilities.
He said the State was seeking to evolve Hyderabad from a location where medicines are manufactured and services delivered into a centre where future healthcare and life sciences technologies are developed.
Tom Wollman, Head of Operational Excellence at Syneos Health, said India has been an important part of the company’s global organisation for more than two decades and that the new centre would bring together leaders, experts and innovators working on new approaches to drug development and commercialisation.
Jinu Jose, General Manager, India and Strategic Growth Hubs, said the centre would bring together global leaders, clinical and commercial experts, technologists and innovators to develop capabilities with global impact.
The opening adds to a broader expansion of global life sciences and technology capabilities in Hyderabad. Earlier in 2026, the Telangana government announced several investments and expansions in the city’s life sciences and healthcare GCC ecosystem, including initiatives involving AI-driven healthcare and life sciences analytics.
Syneos Health said the new centre marks another step in its long-term commitment to India, while Telangana continues to focus on talent, infrastructure and policy support for high-value investments and global capability creation.
